← Back to all trials
Recruiting
NCT05690412
Efficacy and Safety of Endoscopic Papillectomy in the Treatment of Ampullary Neoplasms.
Conditions: Ampullary Adenoma, Ampulla of Vater Adenoma, Ampullary Cancer, Ampulla of Vater Cancer
Sex: All
Ages: 18 Years – N/A
Enrollment: 400
Sponsor: Azienda Unità Sanitaria Locale della Romagna
Location: Italy
Summary
The aim of our study is to provide data on the efficacy and safety of endoscopic papillectomy, by including consecutive patients treated after 2015, when first guidelines on endoscopic management of ampullary neoplasms were available.
Eligibility Criteria
Inclusion Criteria:Ampullary neoplasm, confirmed by histological examination of the endoscopically resected specimenExclusion Criteria:Absence of dysplasia on the resected specimen;Locally advanced or metastatic disease (Clinical TNM stage >T1 or N+ or M+);Neoplasm Intra-Ductal Extension (IDE) > 20 mm;Previously treated ampullary neoplasm.
Source: ClinicalTrials.gov (NCT05690412). StuddyBuddy aggregates publicly available trial information.
